Protalix BioTherapeutics, Inc. (NYSE:PLX) Q4 2019 Earnings Conference Call March 12, 2020 8:30 AM ET Company Participants Monique Kosse - IR, LifeSci Advisors Dror Bashan - President & CEO Eyal Rubin - CFO Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Peter Welford - Jefferies Operator Greetings and welcome to the Protalix Biopharmaceuticals reports Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call. At this time, all participants are in a listen-only mod ...